VaxHub Network

VaxHub is a joint network, co-led by UCL and The University of Oxford, formed at the intersection of two initiatives:
VaxHub Sustainable and VaxHub Global

Launched in September 2023, these programmes bring together world-leading experts in vaccinology, synthetic biology, biochemistry, materials science, and systems engineering. The complementary research programmes are non-disease-specific, focusing on the development and optimisation of various vaccine platform technologies.

VaxHub works with a range of platform technologies:

  • Viral vector vaccines
  • Virus-like particle (VLP) vaccines
  • Subunit vaccines
  • RNA vaccines
  • Glycoconjugate vaccines
The shared VaxHub vision is to improve global health
through more sustainable and equitable vaccine innovation.

VaxHub Sustainable

Funded by the Engineering & Physical Sciences Research Council (EPSRC), this initiative is dedicated to fundamental research aimed at pandemic preparedness through sustainable vaccine manufacturing. Vax-Hub Sustainable focuses on developing advanced vaccine platforms, rapid manufacturing solutions, and needle-free, thermostable formulations.

The goal is to accelerate production processes and improve the storage and distribution efficiency of vaccines, all while emphasising sustainable practices to ensure long-term environmental stewardship in vaccine development.

MArtina-Micheletti

Prof. Martina Micheletti

Co-Director

UCL

Sarah-Gilbert

Prof. Dame Sarah Gilbert

Co-Director

Oxford University

Hub focus

About VaxHub Sustainable

00

funding

0

programme

0

partners

VaxHub Global

Funded by the UK Department of Health and Social Care (DHSC) and the Engineering & Physical Sciences Research Council (EPSRC), Vax-Hub Global’s vision is to deliver flexible, easily transferable multi-product platforms and simplified engineering solutions that enable the development of low cost, effective and globally deployable vaccines to low- and middle-income countries (LMICs).

The hub underpins projects related to different technologies of relevance to a diverse selection of endemic and epidemic pathogens largely affecting (or with the potential to largely affect) LMICs. 

MArtina-Micheletti

Prof. Martina Micheletti

Co-Director

UCL

Cath-Green

Dr. Cath Green

Co-Director

Oxford University

Hub focus

About VaxHub Global

00

funding

0.0

programme

0

partners

Our Funders

Join the Network

Are you interested in accessing the latest research on sustainable vaccine manufacturing, pandemic preparedness, and more equitable global vaccine development? Become a member of the VaxHub network!

contact-section